As its name implies, the foundation of CAR T treatment is T-cells, often called the workhorses of the immune system. In CAR T treatment, the power of these cells are harnessed and boosted to intensify the patients’ natural immune response to eradicate cancer.

Over time, advances in the intracellular engineering of CAR T cells have improved the engineered T cells’ ability to produce more T cells after infusion into the patient and survive longer in the circulation, thus making the treatment more effective.

icon-num1

Collecting, tagging and shipping a patient’s white blood cells to a manufacturing facility

icon-num2

Modifying the patients
T-cells to recognize specific cancers and growing them up

icon-num3

Purifing the patients
T-cells and shipping them back to the patients medical institution for infusion

Our CAR T Areas of Focus

Mustang Bio brings significant expertise to the development of next generation CAR T cell therapy. We are rapidly advancing a number of promising candidates designed to hit unique targets with first in class potential for both hematologic and solid tumor cancers.

To view an overview of our programs, visit our Pipeline page.